A Critical New Drug Is Coming—Unless Agriculture Gets There First
Two long-awaited fungus killers are about to roll out. But if one is widely deployed first, it might breed resistance and make the other useless. ..
Two long-awaited fungus killers are about to roll out. But if one is widely deployed first, it might breed resistance and make the other useless. ..
In a remote part of the Amazon, anthropologists and neuroscientists are learning about life and health without an “embarrassment of riches.” ..
The ovaries age faster than any other organ in the body. Figuring out how to slow down that process could have health benefits for women—and men. ..
Longevity evangelists are injecting people with experimental gene therapies. There are no guarantees—and no refunds. ..
Studying people who live well beyond the age of 100 could reveal the secret to living longer, healthier lives. But the statistics tell another story. ..
Scientists believe lasting symptoms following a coronavirus infection is not a single disorder. New clinical trials could more effectively reach solutions. ..
The single-dose antibiotic regimen dramatically reduces transmission of chlamydia, gonorrhea, and syphilis. But it doesn’t have the CDC’s blessing ..
The Biggest Microbiome Study Sheds Light on Shared Health Risks ..
The nation’s highest court temporarily stayed restrictions on the drug mifepristone while it continues weighing a decision. ..
A Fifth Circuit ruling that keeps mifepristone available, but curtails access to it, is the newest front in a battle over the FDA’s power to approve ..